Based on hormone secretion status, tumors were assigned to four hormone-defined groups (PRL, GH, ACTH or clinical NFPA) supported by WHO histological classification and RNA-seq subtype (Supplementary Table 1a, 1b). The gene discussed is GH1; the disease is non-functioning pituitary adenoma.